Sangamo Therapeutics, Inc (SGMOQ) stock
SGMOQOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.10−0.01 (-8.17%)
Close on Oct 19, 2026Market cap $39.43MP/E –Yield –
Sangamo Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Sangamo Therapeutics's price to book ratio was 21.4× on Jan 30, 2026, against 6.1× a year earlier. Over the last 5 years it ranged from 0.4× to 23.4×, with a median of 2.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jan 30, 2026 | 21.4× | +4.8 |
| 2025 | Dec 31, 2025 | 16.7× | +11.6 |
| 2024 | Dec 31, 2024 | 5.1× | +4.4 |
| 2023 | Dec 29, 2023 | 0.7× | −0.8 |
| 2022 | Dec 30, 2022 | 1.5× | −1.1 |
| 2021 | Dec 31, 2021 | 2.7× | −1.2 |
| 2020 | Dec 31, 2020 | 3.8× | +1.7 |
| 2019 | Dec 31, 2019 | 2.2× | −0.9 |
| 2018 | Dec 31, 2018 | 3.1× | −4.3 |
| 2017 | Dec 29, 2017 | 7.4× | +5.9 |
| 2016 | Dec 30, 2016 | 1.5× | −1.6 |
| 2015 | Dec 31, 2015 | 3.1× | −1.8 |
| 2014 | Dec 31, 2014 | 4.9× | −1.8 |
| 2013 | Dec 31, 2013 | 6.8× | +2.0 |
| 2012 | Dec 31, 2012 | 4.8× | +3.0 |
| 2011 | Dec 30, 2011 | 1.8× | – |
See a number that looks wrong?